N. Jonas & Co., Inc.

Marantech Holding LLC

Antelman Technologies, Ltd.

E.c.r.-electro Chemical Research Ltd.

Tivian Industries, Ltd.

Marvin S Antelman

Niles A Fleischer

Joel Lang

Joost Manassen

Eli Rosh Chodesh

Perry W Antelman

Skin-growth-enhancing compounds and compositions including a therapeutically effective amount of at least one electron active compound, or a pharmaceutically acceptable derivative thereof, that has at least two polyvalent cations, at least one of which has a first valence state and at least one of which has a second, different valence state. Preferred compounds include Bi(III,V) oxide, Co(II,III) oxide, Cu(I,III) oxide, Fe(II,III) oxide, Mn(II,III) oxide, and Pr(III,IV) oxide, and Ag(I,III) oxide, or a combination thereof. These compounds may be in a crystalline state having metallic cations of two different valences, or electronic states, in the inorganic crystal. Also included are articles containing such compositions, such as wound dressings, and methods for facilitating or enhancing skin growth using these compounds, compositions, and articles, such as for the treatment or management of burns or skin grafts.

Compositions for facilitating skin growth and methods and articles using same

The present invention is directed to pharmaceutical compositions that include a therapeutically effective amount of at least one electron active compound, or a pharmaceutically acceptable derivative thereof, that has at least two polyvalent cations, at least one of which has a first valence state and at least one of which has a second, different valence state. Preferred compounds include Bi(III,V) oxide, Co(II,III) oxide, Cu(I,III) oxide, Fe(II,III) oxide, Mn(II,III) oxide, and Pr(III,IV) oxide, and optionally Ag(I,III) oxide. These compounds may be in a crystalline state having metallic cations of two different valences, or electronic states, in the inorganic crystal. In addition, the invention relates to methods for prevention, management, or treatment of a condition using these compounds or pharmaceutical compositions including the same.

Multivalent electron active compositions and methods of making and using same

The invention relates to a method and composition for destroying or inhibiting proliferation of microbes using oxidative fluorinator compounds. Fluoride salts that do not dissociate completely in aqueous solutions, such as tri- or tetravalent transition metal fluorides, inert gas fluorides, or tri- or tetravalent rare earth fluorides, are effective antimicrobial agents even at levels up to about 20 ppm, when used alone or in conjunction with a strong oxidizer.

Oxidative fluorinator compounds as antimicrobials

The present invention provides methods for preventing, treating, and/or managing one or more cancerous conditions in a patient, such as a human. A multivalent metal oxide, such as Ag(I,III), Cu(I,III), Pr(III,IV), and Bi(III,V) oxides or a pharmaceutically acceptable derivative thereof, may be administered to the patient in an amount and for a period of time which is therapeutically effective to prevent, treat, and/or manage such condition(s). These cancerous conditions include systemic and external cancers, and may also include conditions and symptoms associated with cancer. The present invention also provides a pharmaceutical composition suitable for treating such cancerous conditions. The compositions of the invention may be adapted for at least one of subcutaneous injection, intramuscular injection, intravenous injection, infusion, transdermal, or topical application.

Methods of using electron active compounds for managing cancer

Fibrous textile articles possessing enhanced antimicrobial properties are prepared by the deposition or interstitial precipitation of tetrasilver tetroxide (Ag O ) crystals within the interstices of fibers, yarns and/or fabrics forming such articles.

High performance silver (I,III) oxide antimicrobial textile articles

The invention relates to the use of electron active molecular crystals comprising tetrasilver tetroxide (Ag,O,) for the treatment and cure of dermatological skin conditions (diseases) ranging from dermatitis, acne and psoiasis to herpes and skin ulcers.

Tetrasilver tetroxide treatment for skin conditions

Fibrous textile articles possessing enhanced antimicrobial properties are prepared by the deposition or interstitial precipitation of cobalt (II, III) oxide (Co,O,) crystals within the interstices of fibers, yarns and/or fabrics forming such articles.

High performance cobalt (II,III) oxide antimicrobial textile articles

A non-liquid electrolyte containing electrochemical cell which operates efficiently at room temperature. The cell includes (a) a non-liquid electrolyte in which protons are mobile, (b) an anode active material based on an organic compound which is a source of protons during cell discharge, or an anode active material including a metal whose cation can assume at least two different non-zero oxidation numbers and (c) a solid cathode including a compound which forms an electrochemical couple with the anode. Anode and cathode active materials can be chosen so that the cell has the feature that the electrochemical reactions at the anode and cathode are at least partially reversible. An important feature of the cell is that no thermal activation is required for its operation, therefore, the cell efficiently operates under ambient temperatures.

Electrochemical cell with a non-liquid electrolyte

The diamagnetic semiconducting molecular crystal tetrasilver tetroxide (Ag.sub.4 O.sub.4) is utilized for destroying the AIDS virus, destroying AIDS synergistic pathogens and immunity suppressing moieties (ISM) in humans. A single intravenous injection of the devices is all that is required for efficacy at levels of about 40 PPM of human blood. The device molecular crystal contains two mono and two trivalent silver ions capable of 'firing' electrons capable of electrocuting the AIDS virus, pathogens and ISM. When administered into the bloodstream, the device electrons will be triggered by pathogens, a proliferating virus and ISM, and when fired will simultaneously trigger a redox chelation mechanism resulting in divalent silver moieties which chelate and bind active sites of the entities destroying them. The devices are completely non-toxic. However, they put stress on the liver causing hepatomegaly, but there is no loss of liver function.

Method of curing AIDS with tetrasilver tetroxide molecular crystal

Opportunistic decorative mass production gold plating solutions are described which are capable of plating gold at concentrations as low as one-half pennyweight per gallon based on an alkaline gold cyanide complex. The low concentration enables ecological operations as well as low working capital inventory operations. The solutions feature high efficiency 'put through' replenishment of gold, and non 24 Karat gold deposition capabilities such as 18 and 14 Karats without the necessity of adding metal salts. The solutions operate over a pH range of one to seven without affecting the stability of the gold cyanide complex in the pH range of 1-2.5. A preferred embodiment of the invention comprises an electrolyte mixture of three buffer salts and two chelating agents capable of depositing bright hard 18 Karat gold colored deposits.

Gold plating solutions

The employment of molecular crystals as bactericidal, viricidal and algicidal devices, and specifically the molecular semiconductor crystal tetrasilver tetroxide Ag.sub.4 O.sub.4 which has two trivalent and two monovalent silver atoms per molecule, and which through this structural configuration generates electronic activity on a molecular scale capable of killing algae and bacteria via the same mechanism as macroscale electron generators.

Molecular crystal redox device for pharmaceuticals

A novel molecular scale device is described which is bactericidal, fungicidal, viricidal and algicidal. The anti-pathogenic properties of the device are attributed to electron activity indigenous to diamagnetic semiconducting crystals of tetrasilver tetroxide (Ag.sub.4 O.sub.4) which contains two monovalent and two trivalent silver ions in each molecular crystal. When the crystals are activated with an oxidizing agent, they release electrons equivalent to 6.4.times.10.sup.-19 watts per molecule which in effect electrocute pathogens. A multitude of these devices are effective at such low concentrations as 0.3 PPM used as preservatives in a variety of formulations ranging from cosmetics to pharmaceuticals. Indeed, they are intended as active ingredients for pharmaceuticals formulated to destroy such pathogens as Staphylococcus aureus, and epidermidis, the latter of which it completely destroys in a nutrient broth culture of about 1 million organisms at 0.6 PPM, or Candida albercans, the vaginal yeast infection at 2.5 PPM, and the AIDS virus at 18 PPM.

Molecular crystal device for pharmaceuticals

A method of controlling the growth of bacteria and algae in utilitarian bodies of water such as industrial cooling towers, swimming pools and hot tubs is described. The method includes adding to the water trivalent copper compounds including the periodate and chelate complexes of biuret an tris-(hydroxymethyl) aminomethane. These compounds meet EPA standards of killing 100% of select coliforms within 10 minutes and are efficacious at concentrations as low as 5-9 PPM.

Trivalent copper water treatment compositions

A method for controlling the growth of bacteria and algae in utilitarian bodies of water such as industrial cooling towers, swimming pools and hot tubs is described. The method comprises adding to the water novel trivalent silver compounds. Said compounds are light stable and can be supplied as liquid concentrates which will not precipitate any silver whatsoever from saline waters nor will the concentrates stain skin or discolor surfaces. Said compounds meet the rigid EPA standards of killing 100% of select coliforms within ten minutes and are efficacious at concentrations as low as 1-2 PPM.

Trivalent silver water treatment compositions

A novel molecular scale device is described which is bactericidal, fungicidal and algicidal. The antipathogenic properties of the device are attributed to electron activity indigenous to diamagnetic semiconducting crystals of tetrasilver tetroxide (Ag.sub.4 O.sub.4) which contains two monovalent and two trivalent silver ions in each molecular crystal. When the crystals are activated with an oxidizing agent, they release electrons equivalent to 6.4.times.10.sup.-19 watts per molecule which in effect electrocute pathogens. A multitude of these devices are effective at such low concentrations as 0.3 PPM where they can kill 100% of 100 K/cc Streptococcus faecalis, and E. coli colonies in three minutes meeting the ten-minute EPA criteria of 100% kills within ten minutes for swimming pool and hot-tub applications. The devices can be used in utilitarian bodies of water, such as municipal and industrial water reservoirs.

Growing community of inventors

Rehovot, Israel

Marvin S Antelman